PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

M He, C Cao, Z Ni, Y Liu, P Song, S Hao, Y He… - … and Targeted Therapy, 2022 - nature.com
Abstract PROteolysis TArgeting Chimeras (PROTACs) technology is a new protein-
degradation strategy that has emerged in recent years. It uses bifunctional small molecules …

Lipid composition of the cancer cell membrane

W Szlasa, I Zendran, A Zalesińska, M Tarek… - Journal of bioenergetics …, 2020 - Springer
Cancer cell possesses numerous adaptations to resist the immune system response and
chemotherapy. One of the most significant properties of the neoplastic cells is the altered …

Lipid metabolism reprogramming and its potential targets in cancer

C Cheng, F Geng, X Cheng, D Guo - Cancer communications, 2018 - Springer
Reprogramming of lipid metabolism is a newly recognized hallmark of malignancy.
Increased lipid uptake, storage and lipogenesis occur in a variety of cancers and contribute …

Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention

P Karimi, F Islami, S Anandasabapathy… - … , biomarkers & prevention, 2014 - AACR
Less than a century ago, gastric cancer was the most common cancer in the United States
and perhaps throughout the world. Despite its worldwide decline in incidence over the past …

The innovative potential of statins in cancer: new targets for new therapies

E Di Bello, C Zwergel, A Mai, S Valente - Frontiers in chemistry, 2020 - frontiersin.org
Numerous and different types of cancers possess the dysregulation of the mevalonate
pathway as a common feature. Statins, traditionally applied in cardiovascular diseases to …

Molecular and clinical aspects of drug-induced gingival overgrowth

PC Trackman, A Kantarci - Journal of dental research, 2015 - journals.sagepub.com
Drug-induced gingival overgrowth is a tissue-specific condition and is estimated to affect
approximately one million North Americans. Lesions occur principally as side-effects from …

Effects of statins on brain tumors: a review

AR Afshari, H Mollazadeh, NC Henney… - Seminars in Cancer …, 2021 - Elsevier
Evidence from preclinical studies suggests that the competitive HMG-CoA reductase
(HMGCR) inhibitors universally known as' statins,'in addition to being powerful drugs that …

Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs

KK Patel, K Kashfi - Biochemical pharmacology, 2022 - Elsevier
Cholesterol is an amphipathic sterol molecule that is vital for maintaining normal
physiological homeostasis. It is a relatively complicated molecule with 27 carbons whose …

The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis

B Liu, Z Yi, X Guan, YX Zeng, F Ma - Breast cancer research and treatment, 2017 - Springer
Purpose Breast cancer is the most common cancer in females and the leading cause of
death worldwide. The effects of statins on breast cancer prognosis have long been …

Involvement of LDL and ox-LDL in cancer development and its therapeutical potential

CF Deng, N Zhu, TJ Zhao, HF Li, J Gu, DF Liao… - Frontiers in …, 2022 - frontiersin.org
Lipid metabolism disorder is related to an increased risk of tumorigenesis and is involved in
the rapid growth of cancer cells as well as the formation of metastatic lesions …